6IB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innovent Biologics Inc

Watchlist Manager

Watchlist

Price: 11.134 EUR 0.04%

Market Cap: €18.1B

I	Innovent Biologics Inc F:6IB	CN
	Ten Entertainment Group PLC F:6YA	UK
X	Xaar PLC OTC:XAARF	UK
C	Corestate Capital Holding SA DUS:CCAP	LU
	Clean Air Metals Inc F:CKU	CA
	Toleranzia AB F:0EH	SE
	Greatview Aseptic Packaging Co Ltd F:8GA	CN
	IT Link SA F:IL8	FR
Z	Zemaitijos Pienas AB XMUN:IU8	LT
	Cruz Battery Metals Corp F:BR00	CA
	UK Oil & Gas PLC F:0UK	UK
	Zinnwald Lithium PLC F:7WW	UK
	Team Internet Group PLC F:4CN	UK

Profitability Summary

Innovent Biologics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

84%

Gross Margin is Increasing

81% > 87%

Low Operating Margin

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-39% > 7%

Low Net Margin

Negative 3Y Average Net Margin

-4%

Net Margin is Increasing

-27% > 6%

Exceptional Free Cash Flow Margin

71%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-65% > 71%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.